NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $15,000 | +15.4% | 24,425 | 0.0% | 0.00% | – |
| Q3 2020 | $13,000 | -23.5% | 24,425 | 0.0% | 0.00% | – |
| Q2 2020 | $17,000 | -5.6% | 24,425 | 0.0% | 0.00% | – |
| Q1 2020 | $18,000 | -51.4% | 24,425 | 0.0% | 0.00% | – |
| Q4 2019 | $37,000 | -36.2% | 24,425 | -38.0% | 0.00% | – |
| Q3 2019 | $58,000 | +1.8% | 39,386 | -11.5% | 0.00% | – |
| Q2 2019 | $57,000 | -96.7% | 44,481 | -93.3% | 0.00% | – |
| Q1 2019 | $1,733,000 | +88.8% | 664,136 | +19.4% | 0.00% | – |
| Q4 2018 | $918,000 | -58.8% | 556,267 | +21.3% | 0.00% | – |
| Q3 2018 | $2,226,000 | -15.6% | 458,421 | +8.7% | 0.00% | – |
| Q2 2018 | $2,636,000 | -23.2% | 421,827 | +2.1% | 0.00% | – |
| Q1 2018 | $3,431,000 | -17.5% | 413,215 | +1.4% | 0.00% | – |
| Q4 2017 | $4,157,000 | +28.0% | 407,635 | +14.8% | 0.00% | – |
| Q3 2017 | $3,247,000 | +40.4% | 354,991 | +12.0% | 0.00% | – |
| Q2 2017 | $2,312,000 | +31.2% | 316,855 | +29.6% | 0.00% | – |
| Q1 2017 | $1,762,000 | +95.1% | 244,460 | +58.4% | 0.00% | – |
| Q4 2016 | $903,000 | +15.9% | 154,361 | +30.5% | 0.00% | – |
| Q3 2016 | $779,000 | -19.9% | 118,303 | +13.2% | 0.00% | – |
| Q2 2016 | $972,000 | +39.3% | 104,530 | +61.2% | 0.00% | – |
| Q1 2016 | $698,000 | -9.8% | 64,825 | +20.0% | 0.00% | – |
| Q4 2015 | $774,000 | +0.5% | 54,039 | +47.6% | 0.00% | – |
| Q3 2015 | $770,000 | – | 36,604 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|